Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-11-17FDA Approved: NICARDIPINE HYDROCHLORIDE — Original Application (Lifestar Pharma LLC)
FDA approved the original application for nicardipine hydrochloride from Lifestar Pharma LLC, a generic version of the calcium channel block…
-
FDA approval · 2009-11-17FDA Approved: NICARDIPINE HYDROCHLORIDE — Original Application (Archis Pharma LLC)
FDA approved an original application for a generic NICARDIPINE HYDROCHLORIDE product from Archis Pharma LLC.
-
FDA approval · 2009-09-17FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's verapamil hydrochloride as an original generic application, adding a new generic calcium channel blocker to the mark…
-
FDA approval · 2009-09-02FDA Approved: ATENOLOL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Atenolol from Aurobindo Pharma Limited, confirming approval of a generic Atenolol product under …
-
FDA approval · 2009-08-18FDA Approved: BISOPROLOL FUMARATE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a generic version of bisoprolol fumarate from Unichem Pharmaceuticals (USA), Inc. under an Original Application. It is indicate…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-05-28Clinical Trial Update: SPECTACL: SPECTroscopic Assessment of Coronary Lipid [Phase 2, Phase 3]
Phase 2/3 trial update for SPECTACL assessing coronary lipid via spectroscopy in angina conditions; trial completed with results posted in 2…
-
FDA approval · 2009-04-29FDA Approved: TECHNETIUM TC 99M SESTAMIBI — Original Application (Jubilant Draximage (USA) Inc.)
FDA approved Jubilant Draximage (USA) Inc.'s original ANDA for Technetium Tc-99m Sestamibi, a radiopharmaceutical used in myocardial perfusi…
-
FDA approval · 2009-04-08FDA Approved: AMLODIPINE BESYLATE — Original Application (Epic Pharma, LLC)
The FDA approved the original application for amlodipine besylate from Epic Pharma, LLC, enabling its generic version of the calcium channel…
-
FDA approval · 2009-03-12FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved a supplemental application for Teva Pharmaceuticals' amlodipine besylate (generic) product, signaling regulatory approval for t…
-
CLINICAL_TRIALS trial_result · 2009-03-10Clinical Trial Update: Spinal Cord Stimulation (SCS) in Refractory Angina [Phase 4]
This entry reports an update on a Phase 4 clinical trial evaluating spinal cord stimulation for refractory angina, conducted by the Catholic…
-
FDA approval · 2009-02-26FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for metoprolol tartrate from Aurobindo Pharma Limited, confirming regulatory clearance for the gener…
-
FDA approval · 2009-02-19FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Atenolol filed by Zydus Lifesciences Limited, resulting in approval of a generic Atenolol produc…
-
CLINICAL_TRIALS trial_result · 2009-02-19Clinical Trial Update: Rosiglitazone Versus Placebo in Chronic Stable Angina [Phase 4]
A Phase 4 trial comparing rosiglitazone to placebo in chronic stable angina was terminated.
-
FDA approval · 2009-01-14FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
FDA approves a supplemental application for Atenolol by Zydus Lifesciences Limited under an ANDA; this action updates the approved Atenolol …
-
CLINICAL_TRIALS trial_result · 2009-01-08Clinical Trial Update: Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients [Phase 4]
Phase 4 clinical trial update evaluating whether aggressive glucose lowering with pioglitazone reduces in-stent restenosis in patients with …
-
FDA approval · 2008-12-17FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s original application for diltiazem hydrochloride (generic). This approval makes a generic vers…
-
FDA approval · 2008-11-04FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for metoprolol tartrate by Hospira, Inc., indicating regulatory action on this generic product. The …
-
FDA approval · 2008-10-21FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for amlodipine besylate from Aurobindo Pharma Limited (ANDA 078021). This action approves change…
-
FDA approval · 2008-10-21FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Metoprolol Tartrate from Mylan Pharmaceuticals Inc., authorizing a generic version to be mar…
-
CLINICAL_TRIALS trial_result · 2008-10-21Clinical Trial Update: Treatment of Refractory Angina Pectoris by Shock Wave Therapy [Phase 3]
Phase 3 trial update evaluating shock wave therapy for refractory angina pectoris; the current status of the study is unknown.
-
FDA approval · 2008-10-14FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for amlodipine besylate filed by Zydus Pharmaceuticals USA Inc., under the ANDA process.
-
FDA approval · 2008-10-01FDA Approved: NITROGLYCERIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for nitroglycerin by Prasco Laboratories, updating the NDA with additional labeling/indication.
-
FDA approval · 2008-09-10FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for propranolol hydrochloride from Hikma Pharmaceuticals USA Inc., indicating regulatory approval of…
-
FDA approval · 2008-08-29FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for Atenolol from Zydus Lifesciences Limited under the ANDA.
-
FDA approval · 2008-07-31FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved Baxter Healthcare's supplemental application for Cardene IV (nicardipine hydrochloride), adding an intravenous formulation …